Evolus Retained Earnings from 2010 to 2025

EOLS Stock

USD 12.37 0.06 0.48%

Evolus Retained Earnings yearly trend continues to be comparatively stable with very little volatility. Retained Earnings are likely to outpace its year average in 2025. Retained Earnings is the cumulative amount of net income that Evolus Inc retains for reinvestment in its operations, rather than distributing it to shareholders as dividends. View All Fundamentals

Retained Earnings

First Reported

2015-12-31

Previous Quarter

-602.6 M

Current Value

-609.4 M

Quarterly Volatility

191.9 M

Yuan Drop

Covid

Check Evolus financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Evolus' main balance sheet or income statement drivers, such as Depreciation And Amortization of 3.6 M, Interest Expense of 19.7 M or Selling General Administrative of 207.9 M, as well as many indicators such as Price To Sales Ratio of 4.3, Dividend Yield of 0.0 or PTB Ratio of 130. Evolus financial statements analysis is a perfect complement when working with Evolus Valuation or Volatility modules.

Check out the analysis of Evolus Correlation against competitors.

Latest Evolus' Retained Earnings Growth Pattern

Below is the plot of the Retained Earnings of Evolus Inc over the last few years. It is the cumulative amount of net income that a company retains for reinvestment in its operations, rather than distributing it to shareholders as dividends. Evolus' Retained Earnings historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Evolus' overall financial position and show how it may be relating to other accounts over time.

View

Last Reported (609.4 M)

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Retained Earnings

Timeline

Evolus Retained Earnings Regression Statistics

	Arithmetic Mean	(237,652,128)
	Geometric Mean	139,892,622
	Coefficient Of Variation	(95.13)
	Mean Deviation	202,205,285
	Median	(75,543,000)
	Standard Deviation	226,081,847
	Sample Variance	51113T
	Range	562.7M
	R-Value	(0.92)
	Mean Square Error	8270.6T
	R-Squared	0.85
	Slope	(43,754,195)
	Total Sum of Squares	766695T

Evolus Retained Earnings History

	2025	-578.9 M
	2024	-609.4 M
	2023	-559 M
	2022	-497.3 M
	2021	-422.9 M
	2020	-376.1 M
	2019	-213.1 M

Other Fundumenentals of Evolus Inc

Retained Earnings Total Equity

Evolus Retained Earnings component correlations

	Total Assets	Total Stockholder Equity	Net Tangible Assets	Net Debt	Retained Earnings	Accounts Payable	Good Will	Short Term Investments	Total Liab	Deferred Long Term Liab	Short Long Term Debt	Total Current Assets	Short Term Debt	Intangible Assets	Capital Surpluse	Net Receivables	Net Invested Capital	Net Working Capital	Long Term Debt	Capital Stock	Common Stock	Long Term Debt Total	Property Plant Equipment	Current Deferred Revenue
Total Assets		-0.65	0.29	-0.51	-0.79	0.81	-0.32	0.67	0.79	-0.94	0.56	1.0	-0.32	-0.46	0.88	-0.84	-0.2	0.9	0.78	-0.32	-0.32	-0.71	-0.68	0.6
Total Stockholder Equity	-0.65		-0.12	0.25	0.22	-0.46	-0.2	-0.05	-0.51	0.52	-0.26	-0.65	0.02	-0.11	-0.35	0.71	0.06	-0.44	-0.16	-0.2	-0.2	0.25	0.23	0.05
Net Tangible Assets	0.29	-0.12		-0.71	-0.14	0.04	-0.01	0.29	-0.33	-0.16	-0.31	0.3	-0.79	-0.1	0.22	-0.41	0.36	0.62	0.31	-0.01	-0.01	-0.02	-0.34	0.22
Net Debt	-0.51	0.25	-0.71		0.5	-0.47	0.49	-0.51	-0.04	0.36	0.23	-0.5	0.84	0.4	-0.41	0.53	0.1	-0.7	-0.46	0.49	0.49	0.5	0.51	-0.43
Retained Earnings	-0.79	0.22	-0.14	0.5		-0.84	0.57	-0.92	-0.74	0.77	-0.36	-0.79	0.47	0.86	-0.91	0.59	0.48	-0.76	-0.9	0.57	0.57	0.97	0.87	-0.91
Accounts Payable	0.81	-0.46	0.04	-0.47	-0.84		-0.33	0.65	0.76	-0.74	0.31	0.81	-0.38	-0.51	0.8	-0.72	-0.46	0.7	0.74	-0.33	-0.33	-0.82	-0.65	0.64
Good Will	-0.32	-0.2	-0.01	0.49	0.57	-0.33		-0.61	-0.31	0.32	-0.24	-0.3	0.26	0.71	-0.34	-0.01	0.26	-0.32	-0.46	1.0	1.0	0.63	0.44	-0.51
Short Term Investments	0.67	-0.05	0.29	-0.51	-0.92	0.65	-0.61		0.54	-0.66	0.35	0.68	-0.48	-0.93	0.87	-0.41	-0.28	0.72	0.84	-0.61	-0.61	-0.89	-0.95	0.95
Total Liab	0.79	-0.51	-0.33	-0.04	-0.74	0.76	-0.31	0.54		-0.83	0.73	0.79	0.14	-0.46	0.77	-0.56	-0.46	0.51	0.64	-0.31	-0.31	-0.73	-0.51	0.53
Deferred Long Term Liab	-0.94	0.52	-0.16	0.36	0.77	-0.74	0.32	-0.66	-0.83		-0.72	-0.94	0.19	0.51	-0.9	0.82	0.4	-0.85	-0.71	0.32	0.32	0.68	0.61	-0.58
Short Long Term Debt	0.56	-0.26	-0.31	0.23	-0.36	0.31	-0.24	0.35	0.73	-0.72		0.56	0.49	-0.27	0.57	-0.27	-0.17	0.33	0.31	-0.24	-0.24	-0.32	-0.27	0.27
Total Current Assets	1.0	-0.65	0.3	-0.5	-0.79	0.81	-0.3	0.68	0.79	-0.94	0.56		-0.32	-0.46	0.9	-0.85	-0.21	0.9	0.78	-0.3	-0.3	-0.71	-0.69	0.61
Short Term Debt	-0.32	0.02	-0.79	0.84	0.47	-0.38	0.26	-0.48	0.14	0.19	0.49	-0.32		0.4	-0.33	0.46	0.07	-0.63	-0.53	0.26	0.26	0.39	0.48	-0.47
Intangible Assets	-0.46	-0.11	-0.1	0.4	0.86	-0.51	0.71	-0.93	-0.46	0.51	-0.27	-0.46	0.4		-0.7	0.23	0.48	-0.5	-0.68	0.71	0.71	0.88	0.85	-0.87
Capital Surpluse	0.88	-0.35	0.22	-0.41	-0.91	0.8	-0.34	0.87	0.77	-0.9	0.57	0.9	-0.33	-0.7		-0.69	-0.34	0.85	0.85	-0.34	-0.34	-0.82	-0.85	0.85
Net Receivables	-0.84	0.71	-0.41	0.53	0.59	-0.72	-0.01	-0.41	-0.56	0.82	-0.27	-0.85	0.46	0.23	-0.69		0.36	-0.85	-0.55	-0.01	-0.01	0.49	0.45	-0.33
Net Invested Capital	-0.2	0.06	0.36	0.1	0.48	-0.46	0.26	-0.28	-0.46	0.4	-0.17	-0.21	0.07	0.48	-0.34	0.36		-0.15	-0.15	0.26	0.26	0.55	0.2	-0.28
Net Working Capital	0.9	-0.44	0.62	-0.7	-0.76	0.7	-0.32	0.72	0.51	-0.85	0.33	0.9	-0.63	-0.5	0.85	-0.85	-0.15		0.8	-0.32	-0.32	-0.63	-0.7	0.65
Long Term Debt	0.78	-0.16	0.31	-0.46	-0.9	0.74	-0.46	0.84	0.64	-0.71	0.31	0.78	-0.53	-0.68	0.85	-0.55	-0.15	0.8		-0.46	-0.46	-0.78	-0.78	0.87
Capital Stock	-0.32	-0.2	-0.01	0.49	0.57	-0.33	1.0	-0.61	-0.31	0.32	-0.24	-0.3	0.26	0.71	-0.34	-0.01	0.26	-0.32	-0.46		1.0	0.63	0.44	-0.51
Common Stock	-0.32	-0.2	-0.01	0.49	0.57	-0.33	1.0	-0.61	-0.31	0.32	-0.24	-0.3	0.26	0.71	-0.34	-0.01	0.26	-0.32	-0.46	1.0		0.63	0.44	-0.51
Long Term Debt Total	-0.71	0.25	-0.02	0.5	0.97	-0.82	0.63	-0.89	-0.73	0.68	-0.32	-0.71	0.39	0.88	-0.82	0.49	0.55	-0.63	-0.78	0.63	0.63		0.86	-0.85
Property Plant Equipment	-0.68	0.23	-0.34	0.51	0.87	-0.65	0.44	-0.95	-0.51	0.61	-0.27	-0.69	0.48	0.85	-0.85	0.45	0.2	-0.7	-0.78	0.44	0.44	0.86		-0.91
Current Deferred Revenue	0.6	0.05	0.22	-0.43	-0.91	0.64	-0.51	0.95	0.53	-0.58	0.27	0.61	-0.47	-0.87	0.85	-0.33	-0.28	0.65	0.87	-0.51	-0.51	-0.85	-0.91

Click cells to compare fundamentals

About Evolus Financial Statements

Evolus shareholders use historical fundamental indicators, such as Retained Earnings, to determine how well the company is positioned to perform in the future. Although Evolus investors may analyze each financial statement separately, they are all interrelated. The changes in Evolus' assets and liabilities, for example, are also reflected in the revenues and expenses on on Evolus' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.

	Last Reported	Projected for Next Year
Retained Earnings	-609.4 M	-578.9 M
Retained Earnings Total Equity	-447.6 M	-469.9 M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Evolus Stock Analysis

When running Evolus' price analysis, check to measure Evolus' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Evolus is operating at the current time. Most of Evolus' value examination focuses on studying past and present price action to predict the probability of Evolus' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Evolus' price. Additionally, you may evaluate how the addition of Evolus to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC